Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Operating Expenses: 2018-2024

Historic Other Operating Expenses for Organogenesis Holdings (ORGO) over the last 2 years, with Dec 2024 value amounting to $22.8 million.

  • Organogenesis Holdings' Other Operating Expenses rose 38.73% to $37.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is N/A change from last year.
  • Per Organogenesis Holdings' latest filing, its Other Operating Expenses stood at $22.8 million for FY2024, which was up 552.58% from $3.5 million recorded in FY2018.
  • In the past 5 years, Organogenesis Holdings' Other Operating Expenses ranged from a high of $22.8 million in FY2024 and a low of $22.8 million during FY2024.
  • Moreover, its 1-year median value for Other Operating Expenses was $22.8 million (2024), whereas its average is $22.8 million.